USANA HEALTH SCIENCES, INC. (USNA) Gross Margin
- Gross margin · 12 months: Value 77.45%; Formula and calculation Gross profit / revenue. Period ending 2026-07-04..
Gross margin
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 77.45% | Gross profit / revenue. Period ending 2026-07-04. $707.36M ÷ $913.36M × 100 ≈ 77.45% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 707.36M USD | Gross Profit |
| Revenue | 913.36M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 206.00M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-07-04 | $707.36M | $913.36M | $206.00M | 77.45% |
| 2026-04-04 | $718.09M | $925.94M | $207.84M | 77.55% |
| 2026-01-03 | $724.40M | $925.26M | $200.85M | 78.29% |
| 2025-09-27 | $722.67M | $912.67M | $190.00M | 79.18% |
| 2025-06-28 | $718.78M | $899.22M | $180.44M | 79.93% |
| 2025-03-29 | $705.65M | $876.24M | $170.59M | 80.53% |
| 2024-12-28 | $693.29M | $854.50M | $161.21M | 81.13% |
| 2024-09-28 | $697.00M | $861.97M | $164.98M | 80.86% |
| 2024-06-29 | $706.87M | $875.12M | $168.25M | 80.77% |
| 2024-03-30 | $729.21M | $900.45M | $171.24M | 80.98% |
| 2023-12-30 | $744.32M | $921.01M | $176.69M | 80.82% |
| 2023-09-30 | $747.08M | $927.89M | $180.80M | 80.51% |
| 2023-07-01 | $762.99M | $947.82M | $184.84M | 80.50% |
| 2023-04-01 | $783.07M | $974.09M | $191.03M | 80.39% |
| 2022-12-31 | $804.71M | $998.60M | $193.89M | 80.58% |
| 2022-10-01 | $837.96M | $1.04B | $199.98M | 80.73% |
| 2022-07-02 | $874.86M | $1.08B | $204.13M | 81.08% |
| 2022-04-02 | $939.73M | $1.15B | $211.63M | 81.62% |
| 2022-01-01 | $968.57M | $1.19B | $217.90M | 81.63% |
| 2021-10-02 | $1.01B | $1.23B | $224.40M | 81.75% |
| 2021-07-03 | $1.02B | $1.25B | $230.04M | 81.65% |
| 2021-04-03 | $955.30M | $1.18B | $220.70M | 81.23% |
| 2021-01-02 | $925.53M | $1.13B | $209.11M | 81.57% |
| 2020-09-26 | $898.04M | $1.10B | $197.38M | 81.98% |
| 2020-06-27 | $868.66M | $1.06B | $188.84M | 82.14% |
| 2020-03-28 | $866.87M | $1.05B | $187.66M | 82.20% |
| 2019-12-28 | $873.40M | $1.06B | $187.50M | 82.33% |
| 2019-09-28 | $898.95M | $1.09B | $189.68M | 82.58% |
| 2019-06-29 | $931.06M | $1.12B | $193.74M | 82.78% |
| 2019-03-30 | $973.00M | $1.17B | $197.24M | 83.15% |
| 2018-12-29 | $988.54M | $1.19B | $200.71M | 83.12% |
| 2018-09-29 | $966.38M | (m) | (m) | (m) |
| 2018-06-30 | $936.12M | (m) | (m) | (m) |
| 2018-03-31 | $897.82M | (m) | (m) | (m) |
| 2017-12-30 | $867.86M | (m) | (m) | (m) |
| 2017-09-30 | $847.04M | (m) | (m) | (m) |
| 2017-07-01 | $841.65M | (m) | (m) | (m) |
| 2017-04-01 | $841.03M | (m) | (m) | (m) |
| 2016-12-31 | $825.89M | (m) | (m) | (m) |
| 2016-10-01 | $811.72M | (m) | (m) | (m) |
| 2016-07-02 | $794.72M | (m) | (m) | (m) |
| 2016-04-02 | $775.33M | (m) | (m) | (m) |
| 2016-01-02 | $758.82M | (m) | (m) | (m) |
| 2015-10-03 | $756.77M | (m) | (m) | (m) |
| 2015-07-04 | $721.88M | (m) | (m) | (m) |
| 2015-04-04 | $682.12M | (m) | (m) | (m) |
| 2015-01-03 | $649.68M | (m) | (m) | (m) |
| 2014-09-27 | $611.81M | (m) | (m) | (m) |
| 2014-06-28 | $596.65M | (m) | (m) | (m) |
| 2014-03-29 | $600.49M | (m) | (m) | (m) |
| 2013-12-28 | $590.74M | (m) | (m) | (m) |
| 2013-09-28 | $576.61M | (m) | (m) | (m) |
| 2013-06-29 | $569.24M | (m) | (m) | (m) |
| 2013-03-30 | $544.84M | (m) | (m) | (m) |
| 2012-12-29 | $532.92M | (m) | (m) | (m) |
| 2012-09-29 | $515.89M | (m) | (m) | (m) |
| 2012-06-30 | $499.36M | (m) | (m) | (m) |
| 2012-03-31 | $489.25M | (m) | (m) | (m) |
| 2011-12-31 | $480.25M | (m) | (m) | (m) |
| 2011-10-01 | (m) | (m) | (m) | (m) |
| 2011-07-02 | (m) | (m) | (m) | (m) |
| 2011-04-02 | (m) | (m) | (m) | (m) |
| 2011-01-01 | $422.16M | (m) | (m) | (m) |
| 2010-10-02 | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) |
| 2010-01-02 | $347.14M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |